AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48

Authors: DOESVANDENBERG AV VEERMAN AJP VANWERING ER DEVRIES JA DEWAAL FC VANZANEN GE VANWEERDEN JF KAMPS WA
Citation: Av. Doesvandenberg et al., CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN THE NETHERLANDS - RANDOMIZED STUDIES AND NATIONWIDE TREATMENT RESULTS FROM 1972 TO 1995, International journal of pediatric hematology/oncology, 5(2-4), 1998, pp. 125-139

Authors: PIETERS R DENBOER ML DURIAN M JANKA G SCHMIEGELOW K KASPERS GJL VANWERING ER VEERMAN AJP
Citation: R. Pieters et al., RELATION BETWEEN AGE, IMMUNOPHENOTYPE AND IN-VITRO DRUG-RESISTANCE IN395 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT OF INFANTS, Leukemia, 12(9), 1998, pp. 1344-1348

Authors: VANDONGEN JJM SERIU T PANZERGRUMAYER ER BIONDI A PONGERSWILLEMSE MJ CORRAL L STOLZ F SCHRAPPE M MASERA G KAMPS WA GADNER H VANWERING ER LUDWIG WD BASSO G DEBRUIJN MAC CAZZANIGA G HETTINGER A VANDERDOESVANDENBERG A HOP WCJ RIEHM H BARTRAM CR
Citation: Jjm. Vandongen et al., PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDHOOD, Lancet, 352(9142), 1998, pp. 1731-1738

Authors: FORD AM BENNETT CA PRICE CM BRUIN MCA VANWERING ER GREAVES M
Citation: Am. Ford et al., FETAL ORIGINS OF THE TEL-AML1 FUSION GENE IN IDENTICAL-TWINS WITH LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(8), 1998, pp. 4584-4588

Authors: RAMAKERSVANWOERDEN NL PIETERS R KAZEMIER KM VANDRUNEN E HARBOTT J SEYFERT J BEVERLOO HB SLATER R VANWERING ER LUDWIG WD JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., TEL AML1 GENE FUSION IS NOT ASSOCIATED WITH IN-VITRO DRUG-SENSITIVITYIN ACUTE LYMPHOBLASTIC VITRO DRUG LEUKEMIA/, British Journal of Haematology, 102(1), 1998, pp. 231-231

Authors: RAMAKERSVANWOERDEN NL PIETERS R BEVERLOO HB LOONEN AH SLATER R VANWERING ER LUDWIG WD HARBOTT J JANKASCHAUB G SCHMIEGELOW K VEERMAN AJP
Citation: Nl. Ramakersvanwoerden et al., IN-VITRO DRUG-RESISTANCE PROFILE IN MLL-GENE REARRANGED INFANT ACUTE LYMPHOBLASTIC-LEUKEMIA - IMPLICATIONS FOR TREATMENT, British Journal of Haematology, 102(1), 1998, pp. 232-232

Authors: LANGERAK AW WOLVERSTETTERO ILM VANDENBEEMD MWM VANWERING ER LUDWIG WD HAHLEN K NECKER A VANDONGEN JJM
Citation: Aw. Langerak et al., TCR-GAMMA-DELTA(-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS - V-DELTA-1 AND NON-V-DELTA-1 EXPRESSING CASES REPRESENT DISTINCT MATURATION STAGES() T), British Journal of Haematology, 102(1), 1998, pp. 274-274

Authors: DENBOER ML PIETERS R KAZEMIER KM HARMS DO JANKASCHAUB GE VANDERDOESVANDENBERG A KAMPS WA VANWERING ER KASPERS GJL VEERMAN AJP
Citation: Ml. Denboer et al., PROGNOSTIC VALUE OF DRUG-RESISTANCE PROFILES IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 275-275

Authors: PONGERSWILLEMSE MJ VERHAGEN OJHM TIBBE GJM WIJKHUIJS JM DEHAAS V VANWERING ER VANDERSCHOOT CE VANDONGEN JJM
Citation: Mj. Pongerswillemse et al., REAL-TIME PCR FOR QUANTITATIVE DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), British Journal of Haematology, 102(1), 1998, pp. 292-292

Authors: HOOGERBRUGGE PM VERSLUIS HPM VANWERING ER WEERDEN JFW VANDERDOESVANDERBERG A VANWEEL M VANROSSUM M VANTVEER L BLEESING JH VOSSEN JM
Citation: Pm. Hoogerbrugge et al., INTENSIFIED CONDITIONING REGIMEN IN CHILDREN TRANSPLANTED FOR AML IN FIRST AND ALL IN 2ND COMPLETE REMISSION, British Journal of Haematology, 102(1), 1998, pp. 323-323

Authors: KASPERS GJL PIETERS R VANZANTWIJK CH VANWERING ER VANDERDOESVANDENBERG A VEERMAN AJP
Citation: Gjl. Kaspers et al., PREDNISOLONE RESISTANCE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - VITRO-VIVO CORRELATIONS AND CROSS-RESISTANCE TO OTHER DRUGS, Blood, 92(1), 1998, pp. 259-266

Authors: BEISHUIZEN A DEBRUIJN MAC PONGERSWILLEMSE MJ VERHOEVEN MAJ VANWERING ER HAHLEN K BREIT TM DEBRUINVERSTEEG S HOOIJKAAS H VANDONGEN JJM
Citation: A. Beishuizen et al., HETEROGENEITY IN JUNCTIONAL REGIONS OF IMMUNOGLOBULIN-KAPPA DELETING ELEMENT REARRANGEMENTS IN B-CELL LEUKEMIAS - A NEW MOLECULAR TARGET FOR DETECTION OF MINIMAL RESIDUAL DISEASE, Leukemia, 11(12), 1997, pp. 2200-2207

Authors: VERSCHUREN MCM WOLVERSTETTERO ILM BREIT TM NOORDZIJ J VANWERING ER VANDONGEN JJM
Citation: Mcm. Verschuren et al., PREFERENTIAL REARRANGEMENTS OF THE T-CELL RECEPTOR-DELTA-DELETING ELEMENTS IN HUMAN T-CELLS, The Journal of immunology, 158(3), 1997, pp. 1208-1216

Authors: VERVOORDELDONK SF MERLE PA BEHRENDT H STEENBERGEN EJ VANDENBERG H VANWERING ER VONDEMBORNE AEGK VANDERSCHOOT CE VANLEEUWEN EF SLAPERCORTENBACH ICM
Citation: Sf. Vervoordeldonk et al., PCR-POSITIVITY IN HARVESTED BONE-MARROW PREDICTS RELAPSE AFTER TRANSPLANTATION WITH AUTOLOGOUS PURGED BONE-MARROW IN CHILDREN IN 2ND REMISSION OF PRECURSOR B-CELL ACUTE-LEUKEMIA, British Journal of Haematology, 96(2), 1997, pp. 395-402

Authors: KASPERS GJL VEERMAN AJP PIETERS R VANZANTWIJK CH SMETS LA VANWERING ER DENBERG AV
Citation: Gjl. Kaspers et al., IN-VITRO CELLULAR-DRUG RESISTANCE AND PROGNOSIS IN NEWLY-DIAGNOSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 90(7), 1997, pp. 2723-2729

Authors: FORD AM BENNETT CA PRICE CM BRUIN MCA VANWERING ER GREAVES MF
Citation: Am. Ford et al., FETAL ORIGINS OF THE TEL-AML FUSION GENE, Blood, 90(10), 1997, pp. 2475-2475

Authors: KASPERS GJL DENBOER ML PIETERS R JANKA G VANWERING ER VANDERDOESVANDENBERG A VEERMAN AJP
Citation: Gjl. Kaspers et al., IN-VITRO DRUG-RESISTANCE AS IMPORTANT PROGNOSTIC FACTOR IN 2 PROSPECTIVE STUDIES IN CHILDHOOD ALL, Blood, 90(10), 1997, pp. 2521-2521

Authors: COEBERGH JWW VANDERDOESVANDENBERG A HOP WCJ VANWEERDEN F RAMMELOO JA VANSTEENSEL HA VANWERING ER KAMPS WA
Citation: Jww. Coebergh et al., SMALL INFLUENCE OF PARENTAL EDUCATIONAL-LEVEL ON THE SURVIVAL OF CHILDREN WITH LEUKEMIA IN THE NETHERLANDS BETWEEN 1973 AND 1979, European journal of cancer, 32A(2), 1996, pp. 286-289

Authors: KASPERS GJL VEERMAN AJP VANWERING ER VANDERLINDENSCHREVER BEM VANZANTWIJK CH VANDERDOESVANDENBERG A PIETERS R
Citation: Gjl. Kaspers et al., PROGNOSTIC-SIGNIFICANCE OF PEANUT AGGLUTININ BINDING IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 10(4), 1996, pp. 675-681

Authors: VEERMAN AJP HAHLEN K KAMPS WA VANLEEUWEN EF DEVAAN GAM SOLBU G SUCIU S VANWERING ER VANDERDOESVANDENBERG A
Citation: Ajp. Veerman et al., HIGH CURE RATE WITH A MODERATELY INTENSIVE TREATMENT REGIMEN IN NON-HIGH-RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - RESULTS OF PROTOCOL ALL-VI FROM THE DUTCH CHILDHOOD LEUKEMIA STUDY-GROUP, Journal of clinical oncology, 14(3), 1996, pp. 911-918

Authors: KASPERS GJL VEERMAN AJP POPPSNIJDERS C LOMECKY M VANZANTWIJK CH SWINKELS LMJW VANWERING ER PIETERS R
Citation: Gjl. Kaspers et al., COMPARISON OF THE ANTILEUKEMIC ACTIVITY IN-VITRO OF DEXAMETHASONE ANDPREDNISOLONE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 27(2), 1996, pp. 114-121

Authors: KLUINNELEMANS JC VANWERING ER VANTVEER MB VANDERSCHOOT CE ADRIAANSEN HJ VANDERBURGH FJ GRATAMA JW
Citation: Jc. Kluinnelemans et al., PITFALLS IN THE IMMUNOPHENOTYPING OF LEUKEMIA AND LEUKEMIC LYMPHOMAS - SURVEY OF 9 YEARS OF QUALITY-CONTROL IN THE NETHERLANDS, British Journal of Haematology, 95(4), 1996, pp. 692-699

Authors: KLUINNELEMANS JC VANWERING ER VANTVEER MB VANDERSCHOOT CE ADRIAANSEN HJ GRATAMA JW
Citation: Jc. Kluinnelemans et al., PITFALLS IN IMMUNOPHENOTYPING OF LEUKEMIA AND LEUKEMIC LYMPHOMAS, Blood, 88(10), 1996, pp. 1466-1466

Authors: HASLE H ARICO M BASSO G BIONDI A RAJNOLDI AC CREUTZIG U FENU S FONATSCH C HAAS OA HARBOTT J KERNDRUP G MANN G MIHAL V NIEMEYER CM PTOSZKOVA H RITTER J SLATER R STARY J STOLLMANN B TESTI A VANWERING ER ZIMMERMANN M
Citation: H. Hasle et al., MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID-LEUKEMIA (AML) ASSOCIATED WITH COMPLETE OR PARTIAL MONOSOMY 7 - AN EWOG-MDS STUDY OF 111 CHILDREN, Blood, 88(10), 1996, pp. 2325-2325

Authors: KLUINNELEMANS JC GRATAMA JW VANWERING ER VANTVEER MB ADRIAANSEN HJ VANDERSCHOOT CE
Citation: Jc. Kluinnelemans et al., QUALITY ASSESSMENT IN IMMUNOPHENOTYPING OF LEUKEMIA AND LEUKEMIC LYMPHOMAS, Tissue antigens, 48(4-II), 1996, pp. 412-412
Risultati: 1-25 | 26-48